Autopsy report · NCT02216539

Interest of Learning Self-hypnosis for Patients Awaiting Lung Transplantation

“Change of sponsor”

The sponsor’s own words in the registry.

Life of this trial

• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Sponsor type

University, hospital or other

Conditions

Lung Diseases

Interventions

Self-hypnosis; Lung transplantation; Standard post-operative pain management

Participants

5

Sites

1

Countries

France

Trials that died the same way

• VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure
  “Change in Sponsor” (98% match in meaning)
• Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy
  “Sponsor change” (97% match in meaning)
• POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)
  “Change in Sponsor strategy” (86% match in meaning)
• Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients
  “sponsor strategy change” (84% match in meaning)
• Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers
  “Strategic direction of the sponsor changed” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.